Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation

被引:41
作者
Bohm, CM
Mulder, MC
Zennadi, R
Notter, M
SchmittGraff, A
Finn, OJ
TaylorPapadimitriou, J
Stein, H
Clausen, H
Riecken, EO
Hanski, C
机构
[1] FREE UNIV BERLIN,KLINIKUM BENJAMIN FRANKLIN,DEPT GASTROENTEROL,D-12200 BERLIN,GERMANY
[2] FREE UNIV BERLIN,KLINIKUM BENJAMIN FRANKLIN,DEPT HEMATOL,D-12200 BERLIN,GERMANY
[3] FREE UNIV BERLIN,KLINIKUM BENJAMIN FRANKLIN,DEPT PATHOL,D-12200 BERLIN,GERMANY
[4] FREE UNIV AMSTERDAM HOSP,DEPT PATHOL,AMSTERDAM,NETHERLANDS
[5] UNIV PITTSBURGH,SCH MED,DEPT MOL GENET & BIOCHEM,PITTSBURGH,PA 15261
[6] IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND
[7] UNIV COPENHAGEN,SCH DENT,COPENHAGEN,DENMARK
关键词
D O I
10.1046/j.1365-3083.1996.d01-91.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The influence of the epithelial mucin MUC1 on T cell-mediated lysis was analysed using lymph node lymphocytes (LNL) from patients with colorectal carcinoma. LNL were stimulated with allogeneic, MUC1-transfected B cells and the bulk cultures were cloned, Alloreactive cytotoxic T cell clones were obtained which preferentially lysed MUC1-expressing targets. The majority was CD4(+) and MHC-class II-restricted, and a minor group was CD8(+) and MHC-class I-restricted. All the clones expressed CD3 and TCR alpha beta, and were CD56(-). The capacity to preferentially kill MUC1-expressing targets was stable in several clones for up to 6 months in culture, The enhancing effect of MUC1 on the lysis was investigated in more detail. It was only seen after inhibition of O-linked glycosylation in the targets. Furthermore, this effect was completely abrogated by the monoclonal antibody 3C9, directed against the Thomsen-Friedenreich antigen (T-antigen, Gal beta 1-3GalNAc bound alpha 1-3 to Ser/Thr) as well as by the soluble disaccharide Gal beta 1-3GalNAc, but not by other similar disaccharides. The authors conclude that in their system the preferential killing of MUC1-expressing targets is due to the recognition of an internal carbohydrate epitope accessible on underglycosylated MUC1, possibly T-antigen, by an auxiliary receptor molecule on T cells.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 45 条
[1]   VACCINIA VIRUS MUC1 IMMUNIZATION OF MICE - IMMUNE-RESPONSE AND PROTECTION AGAINST THE GROWTH OF MURINE TUMORS BEARING THE MUC1 ANTIGEN [J].
ACRES, RB ;
HAREUVENI, M ;
BALLOUL, JM ;
KIENY, MP .
JOURNAL OF IMMUNOTHERAPY, 1993, 14 (02) :136-143
[2]  
ANDREWS CW, 1993, CANCER-AM CANCER SOC, V72, P3185, DOI 10.1002/1097-0142(19931201)72:11<3185::AID-CNCR2820721109>3.0.CO
[3]  
2-7
[4]  
APOSTOLOPOULOS V, 1994, CANCER RES, V54, P5186
[5]   PRODUCTION OF ANTI-BREAST CANCER MONOCLONAL-ANTIBODIES USING A GLUTATHIONE-S-TRANSFERASE-MUC1 BACTERIAL FUSION PROTEIN [J].
APOSTOLOPOULOS, V ;
XING, PX ;
TRAPANI, JA ;
MCKENZIE, IFC .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :713-720
[6]  
APOSTOLOPOULOS V, 1995, J IMMUNOL, V155, P5089
[7]   SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS [J].
BARND, DL ;
LAN, MS ;
METZGAR, RS ;
FINN, OJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7159-7163
[8]   CIRCULATING ANTIBODIES AGAINST C-MYC ONCOGENE PRODUCT IN SERA OF COLORECTAL-CANCER PATIENTS [J].
BENMAHREZ, K ;
SOROKINE, I ;
THIERRY, D ;
KAWASUMI, T ;
ISHII, S ;
SALMON, R ;
KOHIYAMA, M .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (01) :35-38
[9]   RETRACTED: OLIGOSACCHARIDE LIGANDS FOR NKR-P1 PROTEIN ACTIVATE NK CELLS AND CYTOTOXICITY (Retracted article. See vol. 500, pg. 492, 2013) [J].
BEZOUSKA, K ;
YUEN, CT ;
OBRIEN, J ;
CHILDS, RA ;
CHAI, WG ;
LAWSON, AM ;
DRBAL, K ;
FISEROVA, A ;
POSPISIL, M ;
FEIZI, T .
NATURE, 1994, 372 (6502) :150-157
[10]   THE CARBOHYDRATE-COMPOSITION OF MUCIN IN COLONIC-CANCER [J].
BOLAND, CR ;
DESHMUKH, GD .
GASTROENTEROLOGY, 1990, 98 (05) :1170-1177